Catalyst Pharmaceutical
CPRX • NASDAQ • Stock Fundamentals
Catalyst Pharmaceutical is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard John Daly, with a market cap of $3.8B.
Market Cap$3.8B
Employees167.0
CEORichard John Daly
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Catalyst Pharmaceutical FAQ
Common questions about Catalyst Pharmaceutical
Catalyst Pharmaceutical (CPRX) has a market capitalization of $3.8B and trades on NASDAQ.
Catalyst Pharmaceutical has approximately 167 employees.